mast cell activation disorder

  1. SNT Gatchaman

    Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders, 2025, Stino et al.

    Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders We assessed both objective and subjective measures of autonomic severity in patients with formally classified mast cell activation disorder (MCAD), hereditary alpha tryptasemia (HaT), and...
Back
Top Bottom